Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.
Dardonville Q, Salguiero E, Rousseau V, Chebane L, Faillie JL, Gautier S, Montastruc JL, Carvajal A, Bagheri H.
Eur J Clin Pharmacol. 2019 Dec;75(12):1705-1711. doi: 10.1007/s00228-019-02743-9. Epub 2019 Aug 29.
Stopping Denosumab.
Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG.
Curr Osteoporos Rep. 2019 Feb;17(1):8-15. doi: 10.1007/s11914-019-00502-4.
Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.
Ward LM.
Front Endocrinol (Lausanne). 2020 Dec 16;11:576. doi: 10.3389/fendo.2020.00576. eCollection 2020.
[Glucocorticoid-induced osteoporosis].
Papierska L, Rabijewski M.
Pol Arch Med Wewn. 2007 Aug;117(8):363-9.
Approach to the Pediatric Patient With Glucocorticoid-Induced Osteoporosis.
Ward LM, Bakhamis SA, Koujok K.
J Clin Endocrinol Metab. 2025 Jan 21;110(2):572-591. doi: 10.1210/clinem/dgae507.
Bone-modifying Agents (BMAs) in Breast Cancer.
Shapiro CL.
Clin Breast Cancer. 2021 Oct;21(5):e618-e630. doi: 10.1016/j.clbc.2021.04.009. Epub 2021 Apr 26.
Advances in glucocorticoid-induced osteoporosis.
den Uyl D, Bultink IE, Lems WF.
Curr Rheumatol Rep. 2011 Jun;13(3):233-40. doi: 10.1007/s11926-011-0173-y.
Steroid-induced osteoporosis.
Reid IR.
Osteoporos Int. 1997;7 Suppl 3:S213-6. doi: 10.1007/BF03194375.
[Steroid-induced osteoporosis].
Perrot S, Le Jeunne C.
Presse Med. 2012 Apr;41(4):406-13. doi: 10.1016/j.lpm.2012.01.003. Epub 2012 Feb 7.
RAGE Signaling in Skeletal Biology.
Plotkin LI, Essex AL, Davis HM.
Curr Osteoporos Rep. 2019 Feb;17(1):16-25. doi: 10.1007/s11914-019-00499-w.
